| Grazoprevir plus elbasvir in treatment-naive and treatment-experienced patients with hepatitis C virus genotype 1 infection and stage 4–5 chronic kidney disease (the C-SURFER … D Roth, DR Nelson, A Bruchfeld, AM Liapakis, M Silva, H Monsour, ... The Lancet 386 (10003), 1537-1545, 2015 | 793 | 2015 |
| Prospective multicenter clinical trial of immunosuppressive drug withdrawal in stable adult liver transplant recipients C Benítez, MC Londoño, R Miquel, TM Manzia, JG Abraldes, JJ Lozano, ... Hepatology 58 (5), 1824-1835, 2013 | 302 | 2013 |
| MELD score and serum sodium in the prediction of survival of patients with cirrhosis awaiting liver transplantation MC Londono, A Cárdenas, M Guevara, L Quintó, D de Las Heras, ... Gut 56 (9), 1283-1290, 2007 | 295 | 2007 |
| Sofosbuvir compassionate use program for patients with severe recurrent hepatitis C after liver transplantation X Forns, M Charlton, J Denning, JG McHutchison, WT Symonds, ... Hepatology 61 (5), 1485-1494, 2015 | 253 | 2015 |
| Effects of all-oral anti-viral therapy on HVPG and systemic hemodynamics in patients with hepatitis C virus-associated cirrhosis S Lens, E Alvarado-Tapias, Z Mariño, MC Londoño, E LLop, J Martinez, ... Gastroenterology 153 (5), 1273-1283. e1, 2017 | 251 | 2017 |
| Hyponatremia impairs early posttransplantation outcome in patients with cirrhosis undergoing liver transplantation MC Londoño, M Guevara, A Rimola, M Navasa, P Taurà, A Mas, ... Gastroenterology 130 (4), 1135-1143, 2006 | 226 | 2006 |
| Intra-graft expression of genes involved in iron homeostasis predicts the development of operational tolerance in human liver transplantation F Bohne, M Martínez-Llordella, JJ Lozano, R Miquel, C Benítez, ... The Journal of clinical investigation 122 (1), 368-382, 2012 | 214 | 2012 |
| Portal pressure and liver stiffness measurements in the prediction of fibrosis regression after sustained virological response in recurrent hepatitis C E Mauro, G Crespo, C Montironi, MC Londoño, V Hernández‐Gea, P Ruiz, ... Hepatology 67 (5), 1683-1694, 2018 | 164 | 2018 |
| Virologic, clinical, and immune response outcomes of patients with hepatitis C virus–associated cryoglobulinemia treated with direct-acting antivirals M Bonacci, S Lens, MC Londoño, Z Mariño, MC Cid, M Ramos-Casals, ... Clinical Gastroenterology and Hepatology 15 (4), 575-583. e1, 2017 | 155 | 2017 |
| Comparison of transcriptional and blood cell-phenotypic markers between operationally tolerant liver and kidney recipients JJ Lozano, A Pallier, M Martinez-Llordella, R Danger, M López, M Giral, ... American Journal of Transplantation 11 (9), 1916-1926, 2011 | 130 | 2011 |
| Clinical outcomes of patients undergoing antiviral therapy while awaiting liver transplantation JM Pascasio, C Vinaixa, MT Ferrer, J Colmenero, A Rubin, L Castells, ... Journal of hepatology 67 (6), 1168-1176, 2017 | 128 | 2017 |
| Management of biliary complications after orthotopic liver transplantation: the role of endoscopy MC Londoño, D Balderramo, A Cárdenas World journal of gastroenterology: WJG 14 (4), 493, 2008 | 124 | 2008 |
| Immunosuppression minimization vs. complete drug withdrawal in liver transplantation MC Londoño, A Rimola, J O’Grady, A Sanchez-Fueyo Journal of hepatology 59 (4), 872-879, 2013 | 120 | 2013 |
| Beneficial effect of angiotensin-blocking agents on graft fibrosis in hepatitis C recurrence after liver transplantation A Rimola, MC Londoño, G Guevara, M Bruguera, M Navasa, X Forns, ... Transplantation 78 (5), 686-691, 2004 | 112 | 2004 |
| Efficacy and tolerability of interferon-free antiviral therapy in kidney transplant recipients with chronic hepatitis C I Fernández, R Muñoz-Gómez, JM Pascasio, C Baliellas, N Polanco, ... Journal of hepatology 66 (4), 718-723, 2017 | 100 | 2017 |
| The efficacy of direct anti-HCV drugs improves early post-liver transplant survival and induces significant changes in waiting list composition G Crespo, N Trota, MC Londoño, E Mauro, C Baliellas, L Castells, ... Journal of hepatology 69 (1), 11-17, 2018 | 98 | 2018 |
| Long-term outcomes of patients with HCV-associated cryoglobulinemic vasculitis after virologic cure M Bonacci, S Lens, Z Mariño, MC Londoño, S Rodriguez-Tajes, ... Gastroenterology 155 (2), 311-315. e6, 2018 | 94 | 2018 |
| Daclatasvir combined with sofosbuvir or simeprevir in liver transplant recipients with severe recurrent hepatitis C infection RJ Fontana, RS Brown Jr, A Moreno‐Zamora, M Prieto, S Joshi, ... Liver Transplantation 22 (4), 446-458, 2016 | 92 | 2016 |
| HCV-induced immune responses influence the development of operational tolerance after liver transplantation in humans F Bohne, MC Londoño, C Benítez, R Miquel, M Martínez-Llordella, ... Science translational medicine 6 (242), 242ra81-242ra81, 2014 | 87 | 2014 |
| Elbasvir plus grazoprevir in patients with hepatitis C virus infection and stage 4–5 chronic kidney disease: clinical, virological, and health-related quality-of-life outcomes … A Bruchfeld, D Roth, P Martin, DR Nelson, S Pol, MC Londoño, ... The lancet Gastroenterology & hepatology 2 (8), 585-594, 2017 | 83 | 2017 |
